Obstructive sleep apnea is associated with increased urinary albumin excretion

Sleep

Volumn 30, Issue 7, 2007, Pages 923-929

  Faulx, Michael D ^a,d   Storfer Isser, Amy ^b   Kirchner, H Lester ^b   Jenny, Nancy S ^c   Tracy, Russell P ^c   Redline, Susan ^b  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Endothelium; Epidemiology; Risk factors; Sleep

Indexed keywords

ALBUMIN; CREATININE;

ADULT; APNEA; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SLEEP APNEA SYNDROME; SLEEP DISORDER; URINARY EXCRETION; VASCULAR ENDOTHELIUM;

EID: 34447275709     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/30.7.923     Document Type: Article

References (49)

1. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342(19):1378-84.
2. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003;289(19):2560-72.
3. Bradley TD, Floras JS. Sleep apnea and heart failure part 1: obstructive sleep apnea. Circulation 2003;107(12);1671-8.
4. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163(1):19-25.
5. Yaggi H, Mohsenin V. Obstructive sleep apnoea and stroke. Lancet Neurol 2004;3(6):333-42.
6. Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003;107(20):2589-94.
7. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hyponoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365(9464):1046-53.
8. Gami AS, Howard DE, Olson EJ, et al. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005;352(12):1206-14.
9. Usui K, Bradley TD, Spaak J, Ryan CM, Kubo T, Kanecko Y, Floras JS. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 2005;45(12):2008-11.
10. Naughton MT. The link between obstructive sleep apnea and heart failure: underappreciated opportunity for treatment. Curr Cardiol Rep 2005;7(3):211-5.
11. Ridker PM. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Am Heart J 2004;148 (Suppl 1):S19-26.
12. Yang Y, Loscalzo J. Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation 2000;101(18):2144-8.
13. Ganz P, Vita JA. Testing endothelial vasomotor function, nitric oxide, a multipotent molecule. Circulation 2003;108(17):2049-53.
14. Faulx MD, Wright AT, Hoit BD. The Detection of Endothelial Dysfunction Using Brachial Artery Ultrasonography. Am Heart J 2003;145(6):943-51.
15. Harsch IA, Schahin SP, Radespiel-Troger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004;169(2):156-62.
16. Quan SF, Gersh BJ; National Center on Sleep Disorders Research; National Heart, Lung, and Blood Institute. Cardiovascular consequences of sleep-disordered breathing: past, present, and future. Report of a workshop from the national center on sleep disorders research and the national heart, lung, and blood institute. Circulation 2004;109(8):951-7.
17. Ip MS, Lam B, Chan LY, et al.. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000;162(6):2166-71.
18. Furtner M, Kiechl S, Mair A, et al. Urinary albumin excretion is independently associated with carotid and femoral artery atherosclerosis in the general population. Eur Heart J 2005;26(3):279-87.
19. Gerstein HC, Mann JFE, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286(4):421-6.
20. Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus:the role of endothelial dysfunction. Clin Sci (Lond) 2005;109(2):143-59.
21. Jerums G, MacIsaac RJ. Treatment of microalbuminuria in patients with type 2 diabetes mellitus. Treat Endocrinol 2002;1(3):163-73.
22. Romundstad S, Holmen J, Kvenild K, et al. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trondelag Health Study (HUNT), Norway. Am J Kidney Dis 2003;42(3):466-73.
23. Schwab SJ, Christensen RL, Dougherty K, et al. Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples. Arch Intern Med 1987;147(5):943-4.
24. Jacobs DR Jr, Murtaugh MA, Steffes M, et al. Gender- and race-specific determination of albumin excretion rate using albumin-to-creatinine ratio in single, untimed urine specimens. The coronary artery risk development in young adults study. Am J Epidemiol 2002;155(12):1114-9.
25. Chaudhary BA, Sklar AH, Chaudhary TK, Kolbeck RC, Speir WA. Sleep apnea, proteinuria, and nephrotic syndrome. Sleep 1988;11(1):69-74.
26. Krishna J, Shah ZA, Merchant M, Klein JB, Gozal D. Urinary protein expression patterns in children with sleep-disordered breathing: preliminary findings. Sleep Med 2006;7(3):221-7.
27. Redline S, Tishler PV, Tosteson TD, et al. The familial aggregation of obstructive sleep apnea. Am J Respir Crit Care Med 1995;151(3 Pt 1):682-7.
28. Palmer LJ, Buxbaum SG, Larkin E, et al. A whole genome scan for obstructive sleep apnea and obesity. Am J Hum Genetic 2003;72(2):340-50.
29. American Heart Association recommendations for human blood pressure determination by sphygmomanometers: Report of a Subcommittee of the Postgraduate Education Committee. Dallas, TX, 1980.
30. Kump K, Whalen C, Tishler PV, et al. Assessment of the validity and utility of a sleep symptom questionnaire. Am J Respir Crit Care Med 1994;150(3):735-41.
31. EEG arousals: scoring rules and examples. Sleep 1992;15:173-84.
32. Rechtschaffen A, Kales A. A manual of standardized techniques and scoring system for sleep stages of human subjects. U.S. Government Printing Office Washington, D.C., 1968.
33. Redline S, Sanders MH, Lind BK, et al. Methods for obtaining and analyzing unattended polysomnography data for a multicenter study. Sleep 1998;21(7):759-67.
34. Erlandsen EJ, Randers E, Kristensen JH. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II system. Scand J Clin Lab Invest 1999;59(1):1-8.1
35. Slot C. Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest 1965;17(4):381-7.
36. Grubb A, Björk J, Lindström V, et al. A cystatin C-based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockroft-Gault formula. Scand J Clin Lab Invest 2005;65:153-62.
37. Holm S. A simple sequentially rejective multiple test procedure. Scand J Statistics 1979;6:65-70,
38. Clausen P, Jensen JS, Jensen G, et al. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 2001;103(14):1869-74.
39. Faulx MD, Larkin EK, Hoit BD, et al. Sex Influences Endothelial Function in Sleep-Disordered Breathing. Sleep 2004;27(6):1113-20.
40. Kato M, Roberts-Thompson P, Phillips BG, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000;102(21):2607-10.
41. Dhillon S, Chung SA, Fargher T, et al. Sleep apnea, hypertension, and the effects of continuous positive airway pressure. Am J Hypertens 2005;18 (5 Pt 1):594-600.
42. Klausen KP, Scharling H, Jensen G, et al. New definition of microalbuminuria in hypertensive subjects: association with incident coronary artery disease and death. Hypertension 2005;46(1):33-7.
43. Punjabi NM, Shahar E, Redline S, et al; Sleep Heart Health Study Investigators. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004;160(6):521-30.
44. Resnick HE, Redline S, Shahar E, et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care 2003;26(3):702-9.
45. Weir MR. Microalbuminuria in type 2 diabetics: an important, overlooked cardiovascular risk factor. J Clin Hypertens (Greenwich) 2004;6(3):134-41.
46. Mule G, Nardi E, Cottone S, et al. Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med 2005;257(6):503-13.
47. Wang TJ, Evans JC, Meigs JB, et al. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005;111:1370-6.
48. Bicik Z, Bahcebasi T, Kulaksizoglu S, et al. The efficacy of cystatin C assay in the prediction of glomerular filtration rate. Is it a more reliable marker for renal failure? Clin Chem Lab Med 2005;43(8):855-61.
49. Geluk CA, Asselbergs FW, Hillege HL, et al. Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial. Eur Heart J 2005;26(13):1314-20.